Literature DB >> 14619962

Isoprostanes: more than just mere markers.

D J Crankshaw1, P K Rangachari.   

Abstract

Isoprostanes are members of a family of prostaglandin isomers that are produced by free radical-catalysed mechanisms. They have become well-recognized indicators of oxidant-induced cell damage in a variety of pathophysiological conditions. Several isoprostanes have been shown to possess biological activity in whole-animal, isolated tissue and cell-based systems. Their actions include vasoconstriction, platelet aggregation and cardiac hypertrophy. Current evidence suggests that these effects are mediated by prostanoid receptors through a complex set of interactions that involve agonism, partial agonism, desensitization and co-operative behaviors. It is likely that other mechanisms of action are waiting to be discovered. Based on a consideration of these biological effects, we argue that isoprostanes are more than mere markers and may serve as active participants in promoting and exaggerating pathophysiological changes. To tease out their roles requires considerable more work and a willingness to suspend disbelief based on limited evidence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14619962     DOI: 10.1023/a:1026052123843

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  52 in total

1.  2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite.

Authors:  X Hou; L J Roberts; D F Taber; J D Morrow; K Kanai; F Gobeil; M H Beauchamp; S G Bernier; G Lepage; D R Varma; S Chemtob
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-08       Impact factor: 3.619

2.  8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway.

Authors:  Yin Tintut; Farhad Parhami; Anastasia Tsingotjidou; Sotirios Tetradis; Mary Territo; Linda L Demer
Journal:  J Biol Chem       Date:  2002-02-04       Impact factor: 5.157

3.  Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.

Authors:  J D Morrow; B Frei; A W Longmire; J M Gaziano; S M Lynch; Y Shyr; W E Strauss; J A Oates; L J Roberts
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

4.  Effects of some isoprostanes on the human umbilical artery in vitro.

Authors:  L Oliveira; N A Stallwood; D J Crankshaw
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

5.  Human internal mammary artery contraction by isoprostaglandin f(2alpha) type-III [8-iso-prostaglandin F(2alpha)].

Authors:  J L Cracowski; F Stanke-Labesque; P Devillier; O Chavanon; M Hunt; C Souvignet; G Bessard
Journal:  Eur J Pharmacol       Date:  2000-05-26       Impact factor: 4.432

6.  Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma.

Authors:  M J Reginato; S L Krakow; S T Bailey; M A Lazar
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

7.  Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment.

Authors:  P Wentzel; N Welsh; U J Eriksson
Journal:  Diabetes       Date:  1999-04       Impact factor: 9.461

Review 8.  Are endothelium-derived hyperpolarizing and contracting factors isoprostanes?

Authors:  Luke J Janssen
Journal:  Trends Pharmacol Sci       Date:  2002-02       Impact factor: 14.819

9.  Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.

Authors:  K Takahashi; T M Nammour; M Fukunaga; J Ebert; J D Morrow; L J Roberts; R L Hoover; K F Badr
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

10.  Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo.

Authors:  J D Morrow; T A Minton; K F Badr; L J Roberts
Journal:  Biochim Biophys Acta       Date:  1994-01-03
View more
  3 in total

1.  Dual effect of isoprostanes on the release of [3H]D-aspartate from isolated bovine retinae: role of arachidonic acid metabolites.

Authors:  Catherine A Opere; Wei Dong Zheng; Jifan Huang; Adeniran Adewale; Michael Kruglet; Sunny E Ohia
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

2.  Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus.

Authors:  Jian-Xiong Chen; Patrick W O'Mara; Stanley D Poole; Naoko Brown; Noah J Ehinger; James C Slaughter; Bibhash C Paria; Judy L Aschner; Jeff Reese
Journal:  Pediatr Res       Date:  2012-08       Impact factor: 3.756

3.  Curcumin reduces enteric isoprostane 8-iso-PGF2α and prostaglandin GF2α in specific pathogen-free Leghorn chickens challenged with Eimeria maxima.

Authors:  Victor M Petrone-Garcia; Raquel Lopez-Arellano; Gabriela Rodríguez Patiño; Miriam Aide Castillo Rodríguez; Daniel Hernandez-Patlan; Bruno Solis-Cruz; Xochitl Hernandez-Velasco; Fernando Alba-Hurtado; Christine N Vuong; Inkar Castellanos-Huerta; Guillermo Tellez-Isaias
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.